Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Image of the MS-UK Helpline button graphic containing a link to the Helpline page

Image of the New Pathways magazine button graphic containing a link to the New Pathways magazine page


American drug company Alvogen says it has launched Remurel, the first generic equivalent of Copaxone, in Central and Eastern Europe.

The product will be marketed as a once-daily...

Scientists are challenging a recent study that claimed to identify a rare genetic mutation which boosted the risk of multiple sclerosis.

They cite calculation errors and say they have been...

Tamoxifen, also known as Nolvadex, a widely used treatment for breast cancer, could also be used to treat myelin loss in patients with multiple sclerosis (MS), a new study suggests.

The...

Almost half of people with multiple sclerosis have experienced mistreatment or stigma as a result of their symptoms, a survey has revealed. 

The study by the MS Society found that 49 per...

Multiple sclerosis patients are at risk of developing lymphopenia, or abnormally low levels of immune defense white blood cells, called lymphocytes, according to a new study.
 
...

A new study claims a healthier lifestyle is strongly associated with lower chances of an MS patient having mobility issues. 

The study, Associations Of Lifestyle, Medication, And Socio-...

A number of common conditions are mistaken for multiple sclerosis say researchers at four academic medical centres across the U.S. in a study published in the journal Neurology.

While...

Multiple sclerosis seems to be less severe in people with higher levels of the minor adult hemoglobin variant A2 (HbA2) in their blood, possibly because this variant works to protect and stabilize...

New research has found that Amiselimod “significantly” reduces the number of MS-related lesions found in various brain areas. 

In the study, researchers compared the safety and efficacy of...

People with relapsing multiple sclerosis who use a device called RebiSmart to self-inject medications like Rebif are more...

Pages

Live Chat Software by Click4Assistance UK